University Medical Center
Ho Chi Minh City, Vietnam
NCT Number: NCT07825519
This randomized controlled trial aims to evaluate the effectiveness of enhanced web-based health education on self-care practices and quality of life among patients with hepatocellular carcinoma. A total of 252 participants undergoing transarterial chemoembolization (TACE) will be randomly assigned to an intervention group or a control group. The intervention group will receive routine health education combined with enhanced web-based health education, while the control group will receive routine health education and printed educational materials. Knowledge, self-care practices, and quality of life will be assessed at baseline, 1 month, and 3 months after TACE. The study will determine whether enhanced web-based health education can improve self-care practices and quality of life in patients with hepatocellular carcinoma undergoing TACE.
This study is active but is not currently recruiting participants.
Notify Me18 year and older
All sexes
Interventional
Not applicable
Ho Chi Minh City, Vietnam
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Participants in the intervention group will receive routine health education combined with an enhanced web-based health education program designed to support self-care among patients with hepatocellular carcinoma undergoing TACE. The web-based program provides educational content on hepatocellular carcinoma and TACE, preparation for TACE, post-TACE care, management of common symptoms, nutrition, medication adherence, warning signs, follow-up care, and self-care practices. Educational information is delivered through written materials, images, and videos and can be accessed by participants during the study period.
Participants in the control group will receive routine health education and printed educational materials according to usual care for patients undergoing TACE.
Time frame: Baseline, 1 month, and 3 months after TACE
Knowledge will be assessed using a 17-item researcher-developed questionnaire. Higher scores indicate better knowledge. The instrument was evaluated for content validity and demonstrated high internal consistency, with a Cronbach's alpha of 0.93.
Time frame: Baseline, 1 month, and 3 months after TACE
Self-care practices will be assessed using a 15-item researcher-developed questionnaire. Each item is rated on a 5-point Likert scale, with higher scores indicating better self-care practices. The instrument was evaluated for content validity and demonstrated acceptable internal consistency, with a Cronbach's alpha of 0.72.
Time frame: Baseline, 1 month, and 3 months after TACE
Quality of life will be assessed using the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire-Core 30 (EORTC QLQ-C30). The questionnaire consists of 30 items comprising five functional scales (physical, role, emotional, cognitive, and social functioning), three symptom scales (fatigue, nausea/vomiting, and pain), a global health status/quality of life scale, and six single-item symptom measures. Scores are transformed to a 0-100 scale according to the EORTC scoring procedures. Higher scores on the functional scales and global health status/quality of life scale indicate better functioning and quality of life, whereas higher scores on the symptom scales/items indicate greater symptom burden.
University Medical Center Ho Chi Minh City (UMC)
Other
Effectiveness of Enhanced Web-Based Health Education on Self-Care Practices and Quality of Life Among Patients With Hepatocellular Carcinoma
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07581769
Adenocarcinoma, Carcinoma
Guangzhou, Guangdong, China
View Trial DetailsNCT07562763
Adenocarcinoma, Adjuvant Therapy
Hefei, Anhu, China
View Trial DetailsNCT07543510
Adenocarcinoma, Atezolizumab Plus Bevacizumab
View Trial DetailsNCT07449065
Adenocarcinoma, Carcinoma
Guangzhou, Guangdong, China
View Trial Details